JB Chemicals & Pharmaceuticals Limited
J.B. Chemicals and Pharmaceuticals Limited, established in 1976, is one of India's leading pharmaceutical companies. An integrated, publicly-listed organization with a focus on supplying affordable, quality products both in India and internationally, JBCPL is trusted by healthcare professionals globally.
What JB files
- Others72
- Important35
- Investor Meet23
- Updates22
- Dividend/Bonus9
- Board Meeting8
JB Pharma reported strong Q3 FY26 revenue of 1,065 Cr, up 11% YoY, with 9M FY26 revenue reaching 3,244 Cr, up 9%. Domestic formulations grew 10% to 620 Cr, outpacing the Indian pharma market. International business climbed 12% to 445 Cr, fueled by a 20% surge in international formulations. The...
JB Pharma delivered a strong Q2 FY26. **Business Performance**: Revenue grew 8% YoY to 1,085 Cr, with Domestic Formulations up 9% to 644 Cr, outpacing the market. International business rose 7% to 441 Cr, buoyed by strong CDMO growth. Net Profit surged 19% to 208 Cr, and Operating EBITDA increased...
**Financial Highlights:** JB Pharma's Q1 FY26 revenue grew 9% YoY to INR 1094 Cr, with domestic formulations up 14% (INR 678 Cr). Operating EBITDA jumped 13% to INR 330 Cr, margins hitting 30.2% (first time >30%). Gross margins improved to 68.3%. Net Profit increased 14% YoY to INR 202 Cr,...
1. Financial Highlights: JB Chemicals delivered a revenue CAGR of 18% from FY21 to FY25 with strong contribution from India (58%) driven by 6 brands in the IPM Top 300 and 3 in cardiology’s Top 25. Torrent Pharmaceuticals grew revenue at a CAGR of 10% over the same period, with...
1. Financial Highlights: JB Pharma’s revenue rose 12% to INR 3,918 Cr in FY25, driven by a 20% jump in Domestic formulations (INR 2,269 Cr) and 4% growth in International business (INR 1,649 Cr). Q4 revenue grew 10% YoY to INR 949 Cr, led by Domestic sales (INR 519 Cr,...